Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Which biotechs are the least efficient?
Fierce Biotech
Friday, August 20, 2010 - 12:53pm
tags:
MannKind, Orexigen, Aastrom, Hemispherx, Cell Therapeutics
Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
BNET Pharma
Friday, August 20, 2010 - 12:51pm
tags:
Elan, SEC, epilepsy, lorazepam, Amarin
Dividends Aren't Enough: Biotech
Motley Fool
Friday, August 20, 2010 - 12:48pm
tags:
biotech, Gilead Sciences, Amgen, Genzyme, Biogen Idec, Dendreon
Analyst:Cymbalta sales won't offset Lilly's losses
Yahoo/AP
Friday, August 20, 2010 - 12:47pm
tags:
Cymbalta, FDA, Eli Lilly, chronic pain
CEO Is Latest Hospira Exec Hitting The Road
Forbes
Friday, August 20, 2010 - 12:46pm
tags:
Pharma CEOs, Christopher Begley, Hospira
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Forbes
Friday, August 20, 2010 - 12:45pm
tags:
Eli Lilly, Alzheimer's disease, Pfizer, Elan, Bristol-Myers Squibb
Impax Labs challenges Vytorin patents
Yahoo/AP
Friday, August 20, 2010 - 10:57am
tags:
Vytorin, Impax Labs, patents, Merck
Generic Risk For Gilead's Hepsera
Yahoo/Zacks.com
Friday, August 20, 2010 - 10:56am
tags:
Gilead Sciences, Hepsera, generics, Bristol-Myers Squibb, Merck, hepatitis B
Lilly Wins Panel's Backing to Expand Cymbalta in Pain
Bloomberg
Friday, August 20, 2010 - 8:45am
tags:
Cymbalta, Eli Lilly, FDA, chronic pain
Jazz Pharma: FDA Panel Live Blog
TheStreet.com
Friday, August 20, 2010 - 8:42am
tags:
Jazz Pharmaceuticals, FDA, advisory panels, JZP-6, fibromyalgia
Why Cumberland Pharma Needs Acetadote Approval to Avert Disaster
Seeking Alpha
Friday, August 20, 2010 - 8:41am
tags:
Cumberland, Acetadote, liver failure, generics
Cephalon sues Apotex in Nuvigil patent dispute
Yahoo/AP
Thursday, August 19, 2010 - 8:01pm
tags:
Cephalon, NUVIGIL, patents, Apotex
Plenty of Work for Pharmaceutical Sales Representatives, if only…
Pharmareform
Thursday, August 19, 2010 - 5:33pm
tags:
drug reps, healthcare reform
10 Years Later, Glaxo Still Haunted by Faked Studies of Paxil in Kids
BNET Pharma
Thursday, August 19, 2010 - 5:33pm
tags:
GSK, Paxil, pediatrics, antidepressants
Buffett Is Buying J&J. Should You?
Motley Fool
Thursday, August 19, 2010 - 5:32pm
tags:
JNJ, Warren Buffett
Avanir Expected to Shine at the American Neurological Association Meeting
Seeking Alpha
Thursday, August 19, 2010 - 5:30pm
tags:
Avanir, PBA
[video]They Just Don't Get Lilly!
Yahoo/TheStreet.com
Thursday, August 19, 2010 - 11:08am
tags:
Eli Lilly
Traders Gobbling Up Shares of KV Pharmaceutical, Shares Up 9.7% (KV.A)
Comtex Smartrend
Thursday, August 19, 2010 - 10:56am
tags:
KV Pharmaceutical
Novartis sales calls to healthcare providers on the rise
Fierce Pharma
Thursday, August 19, 2010 - 10:36am
tags:
Novartis, drug reps, physicians
Pfizer Menopause Drug Didn't Cause Cancers, Jury Says
Bloomberg
Thursday, August 19, 2010 - 10:34am
tags:
Pfizer, HRT, cancer, Prempro, Wyeth

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.